Evidence map›Paper›PMID 40642710›Full record

ArticleCureus2025

Pituitary Mimic: Sellar Meningioma in a Patient Undergoing Fertility Therapy.

Zeinab Alnahas, Anas Kartoumah, Talal Alomar, Kareem Masalkhi, Mohamad Horani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zeinab AlnahasInternal Medicine, Cairo University, Cairo, EGY.
Anas KartoumahBiomedical Sciences, University of South Florida, Tampa, USA.
Talal AlomarInternal Medicine, Creighton University School of Medicine, Phoenix, USA.
Kareem MasalkhiBiology, Arizona State University, Phoenix, USA.
Mohamad HoraniInternal Medicine, Chandler Regional Medical Center, Chandler, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sex hormones play a crucial role in the development and growth of meningioma. It was observed that meningiomas increase in size and become more symptomatic during pregnancy. Similarly, the use of hormonal therapy, including gonadotropin-releasing hormone (GnRH) agonist, can be associated with an increased risk for meningioma. We reported a 45-year-old woman with a past medical history of hypothyroidism and mild hyperprolactinemia who received hormonal therapy for infertility, including GnRH. She has experienced a persistent headache and left retro-orbital pain with eye movement. Her MRI brain scan revealed a soft tissue mass involving the sellar and left cavernous sinus with a slight impingement of the optic chiasm and left optic nerve, concerning for meningioma or pituitary adenoma. Further laboratory workup showed secondary adrenal insufficiency, which was treated with replacement glucocorticoid therapy. Following tumor resection and histological examination, the diagnosis of sellar meningioma was confirmed. This case report shows a rare association of fertility hormonal treatment with sellar meningioma and how it is challenging to distinguish meningioma from other sellar masses, such as pituitary adenoma, based on clinical presentation and imaging studies.

Indexed as

fertility treatmentgonadotropin-releasing hormonemeningiomasecondary adrenal insufficiencysellar mass

Identifiers

PMID40642710
PMCPMC12242357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.